Kevin Joseph Fitzgerald is CSO & VP at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 7 open-market trades across 1 company since 2024, most recently 2026-04-07.
CIK 0001886431
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALNY | 20,569 | $4.8M |
| OVID | 17,578 | $38K |
| Total | $4.8M |
Shares reported on the most recent Form 4, priced at the 2026-04-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALNY | SELL | 2026-03-04 | 2026-03-06 | $323.54 | $418K | -0.8% | +4.1% | -4.3% |
| ALNY | SELL | 2026-03-02 | 2026-03-04 | $323.62 | $1.1M | -1.5% | +2.1% | -11.6% |
| ALNY | SELL · 10b5-1 | 2026-02-13 | 2026-02-17 | $321.24 | $1.3M | +1.2% | -5.4% | -13.0% |
| ALNY | SELL | 2026-01-12 | 2026-01-14 | $367.37 | $1.4M | -3.7% | -14.7% | -7.9% |
| ALNY | SELL · 10b5-1 | 2025-11-17 | 2025-11-19 | $453.75 | $7.1M | +0.3% | -13.6% | -28.2% |
| ALNY | SELL | 2025-10-02 | 2025-10-03 | $452.15 | $2.1M | +2.5% | -5.4% | -12.8% |
| ALNY | SELL | 2025-08-18 | 2025-08-19 | $453.54 | $1.1M | -2.8% | -1.6% | +0.3% |
| ALNY | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $242.92 | $1.2M | +3.5% | -3.6% | +24.2% |
| ALNY | SELL | 2025-02-28 | 2025-03-03 | $241.69 | $120K | +0.3% | +10.7% | +27.0% |
| ALNY | SELL · 10b5-1 | 2025-02-14 | 2025-02-18 | $251.86 | $803K | -1.4% | +1.3% | +16.7% |
| ALNY | SELL · 10b5-1 | 2024-11-26 | 2024-11-27 | $251.68 | $1.4M | +1.3% | -5.0% | -2.2% |
| ALNY | SELL · 10b5-1 | 2024-08-12 | 2024-08-14 | $270.98 | $11.9M | +2.4% | +0.9% | +2.3% |
| ALNY | SELL | 2024-06-25 | 2024-06-26 | $230.82 | $329K | +4.0% | -4.1% | +10.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.